{"id":34159,"date":"2023-08-15T23:54:05","date_gmt":"2023-08-15T21:54:05","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/"},"modified":"2023-08-15T23:54:05","modified_gmt":"2023-08-15T21:54:05","slug":"ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l","status":"publish","type":"press_release","link":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/","title":{"rendered":"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients"},"content":{"rendered":"<ul>\n<li style=\"margin-bottom:3px\">Le nouveau dispositif \u00e9lectronique d\u2019auto-injection est con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients atteints de tumeurs neuroendocrines gastroent\u00e9ro-pancr\u00e9atiques, du syndrome carcino\u00efde ou d\u2019acrom\u00e9galie.<\/li>\n<li style=\"margin-bottom:3px\">\u00c9tudes de performance et de s\u00e9curit\u00e9 en cours ; premiers lancements du nouveau dispositif pr\u00e9vus pour 2024.<\/li>\n<li style=\"margin-bottom:3px\">Un dispositif Somatuline\u00ae\u00a0Autogel\u00ae\u00a0\/ Somatuline\u00ae\u00a0Depot de quatri\u00e8me g\u00e9n\u00e9ration, fruit de 20 ann\u00e9es d\u2019expertise.<\/li>\n<\/ul>\n<p>PARIS, FRANCE, le 16 mars 2022 \u2013 Ipsen (Euronext : IPN ; ADR : IPSEY) a annonc\u00e9 aujourd\u2019hui son investissement dans un nouveau dispositif \u00e9lectronique d\u2019auto-injection de Somatuline\u00ae\u00a0Autogel\u00ae\u00a0\/ Somatuline\u00ae\u00a0Depot (lanreotide) \u00e0 la pointe de l\u2019innovation, en vue d\u2019am\u00e9liorer l\u2019administration et l\u2019exp\u00e9rience d\u2019injection des patients. Le nouveau dispositif sera fabriqu\u00e9 en collaboration avec Phillips-Medisize, leader mondial des solutions de conception, de d\u00e9veloppement et de fabrication de m\u00e9dicaments. Le Groupe pr\u00e9voit par ailleurs d\u2019accro\u00eetre ses investissements dans le site de fabrication d\u2019Ipsen \u00e0 Signes (France). Cette \u00e9tape importante a pu \u00eatre franchie gr\u00e2ce aux 20 ann\u00e9es d\u2019exp\u00e9rience d\u2019Ipsen avec Somatuline Autogel \/ Somatuline Depot. L\u2019annonce faite ce jour marque la quatri\u00e8me g\u00e9n\u00e9ration de dispositifs con\u00e7us pour administrer ce m\u00e9dicament.<br \/>Malgr\u00e9 les progr\u00e8s technologiques, des preuves concr\u00e8tes sugg\u00e8rent que les personnes atteintes de tumeurs neuroendocrines gastro-ent\u00e9ro-pancr\u00e9atiques ou d\u2019acrom\u00e9galie ressentent encore souvent une douleur et de l\u2019inconfort lorsqu\u2019elles re\u00e7oivent des injections1. Le nouveau syst\u00e8me d\u2019administration am\u00e9liorera l\u2019exp\u00e9rience du patient lors de l\u2019administration de Somatuline Autogel \/ Somatuline Depot gr\u00e2ce \u00e0 son appareil motoris\u00e9, compos\u00e9 d\u2019un dispositif d\u2019injection \u00e9lectronique r\u00e9utilisable et d\u2019une cartouche jetable avec une aiguille d\u2019injection nettement plus fine qui permet une injection contr\u00f4l\u00e9e et prolong\u00e9e. Ce nouveau dispositif vise \u00e0 am\u00e9liorer l\u2019exp\u00e9rience d\u2019injection, en particulier pour les soignants et les patients \u00e9ligibles qui opteraient pour l\u2019administration ind\u00e9pendante* de Somatuline Autogel, par exemple l\u2019auto-injection ou l\u2019injection par le conjoint.<br \/>L\u2019exp\u00e9rience acquise par Ipsen avec Somatuline Autogel \/ Somatuline Depot a permis de mieux comprendre les d\u00e9fis des patients vivant avec des tumeurs neuroendocrines gastro-ent\u00e9ropancr\u00e9atiques, le syndrome carcino\u00efde ou l\u2019acrom\u00e9galie. Les progr\u00e8s en mati\u00e8re d\u2019administration sont importants, car ils contribuent \u00e0 att\u00e9nuer les d\u00e9fis physiques du traitement pour le patient, son aidant et son \u00e9quipe de soins de sant\u00e9, en particulier pour les patients qui suivent des traitements \u00e0 long terme.<br \/>Steven Hildemann, M.D., PhD, Vice-Pr\u00e9sident Ex\u00e9cutif, Chief Medical Officer, Responsable des Affaires m\u00e9dicales Monde et de la S\u00e9curit\u00e9 des Patients, Ipsen, a d\u00e9clar\u00e9 :\u00a0<em>\u00ab Ipsen continue d\u2019innover afin d\u2019offrir des dispositifs toujours plus fonctionnels d\u2019administration de Somatuline Autogel \/ Somatuline Depot. Cette nouvelle annonce faite ce jour t\u00e9moigne de notre engagement sans rel\u00e2che \u00e0 am\u00e9liorer l\u2019exp\u00e9rience d\u2019injection pour les patients, les aidants et les professionnels de sant\u00e9. Nous continuons de nous focaliser sur l\u2019am\u00e9lioration d\u2019un dispositif d\u00e9j\u00e0 convaincant, afin de mieux r\u00e9pondre aux besoins des personnes vivant avec des tumeurs neuroendocrines gastro-ent\u00e9ro-pancr\u00e9atiques, le syndrome carcino\u00efde ou l\u2019acrom\u00e9galie. \u00bb<\/em><br \/>Des \u00e9tudes \u00e9valuant les performances et la s\u00e9curit\u00e9 du nouveau dispositif sont en cours. Une \u00e9tude \u00e9valuant la douleur au site d\u2019injection et la s\u00e9curit\u00e9 du dispositif devrait d\u00e9buter au premier semestre 2023 pour \u00e9valuer les r\u00e9sultats rapport\u00e9s par les patients. Les d\u00e9tails de cette \u00e9tude seront disponibles sur clinicaltrials.gov d\u00e8s que la s\u00e9lection des centres sera finalis\u00e9e au premier semestre 2022, les premiers lancements op\u00e9rationnels \u00e9tant pr\u00e9vus pour 2024. L\u2019enveloppe d\u2019investissement global dans le d\u00e9veloppement du nouveau dispositif et le montant des ressources suppl\u00e9mentaires allou\u00e9es au site de fabrication d\u2019Ipsen Signes s\u2019\u00e9l\u00e8vent \u00e0 environ 60 millions d\u2019euros.<\/p>\n<p><b>R\u00e9f\u00e9rences<\/b><\/p>\n<ol>\n<li style=\"margin-bottom:3px\">O\u2019Toole D. et al. ENETS 2022. PRESTO 2: an international patient survey to evaluate impact of injection<br \/>and delivery system on local pain when administering somatostatin analogue (SSA) therapy<\/li>\n<li style=\"margin-bottom:3px\">Somatuline Autogel (lanreotide acetate) SmPC. Last accessed: February 2022. Available from:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GNP0ev44d6XHeNzX0M24HtHBD9ydmL3HDt9bL6-jdEsTMvPHv3ozbZ9MOlr0wkF6v8r2iQE_fLCPPrN9XZZsaCQoC31rfhMD1DaS5sTKS9w1WfDZzpM4Y8KpoKA9SqCwzR4U6KRAo_1znLDbw-68OsmtP8qOUMJkhJrPlpAsd3P5-vHCYLP8qp2T-FUNUVfd\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>https:\/\/www.medicines.org.uk\/emc\/product\/4808\/smpc<\/b><\/a><\/li>\n<li style=\"margin-bottom:3px\">Neuroendocrine Tumour (NETs). Macmillan. Last accessed: February 2022. Available from:<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GNP0ev44d6XHeNzX0M24HnqhCJ6ZZDcYL8IFkvrbTSh5EB-LySQoIJb6-EbxSaIlGRS95krBbOJbw3V3SIyAMf53z3LiYlV1aia_vafOlzHiIIRUsM5UZF1TzHkBj-SXU-xKBgm61QK09Nj21btM6TGbnqJ6ONUFlJOwVR04_5yQAZU_eXsxQd62_F-GZCBO5n16QB1WCu2as-W8mp0Pbw==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>https:\/\/www.macmillan.org.uk\/cancer<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxISYPct7CV6eWxUORjGnGOphFw_2wbqMSyhj8DgjS3HZNW_X53X4Uln8CRo8WoIt5mdyGC0qBmuknOu9VOM-4_l0jHEnvOp1ciGtQJzY6aQsQKbOrgNH9xPS4R0b7ZZIv4YbdZ0NR_Yp-kL0eCP8FrkY=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=okK5vHvhZRCuHH5dUjOBs7smaNo8nB7vGze4Ulol9d9x5UuRqZKb6JIYC2fHQD6GzNYcY4IJ1BWNi2ZuXjBDiEJgUBjFENX7fLxx3Plc87_PeNnxeAWfKNt3ilFwSgiy8CZxSMp_GOCV7KDLScQGQGGNpEKjIENBnTYZ8ZijkrU=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>information<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIT92kWKPowREBbgQS3cj8hm3gJK84fUBHV-O4h-A4H-uSw79jW6WIWy9S0Sr5Qb2J9jdU_3A8sY12KAi_8ibSOdgF1_qvH0vyp2ySTgQRuLDYEHileKiwON_HyjS4KicJ3OFBueoJHB0y8YpK5O1NHE=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Uj8tEKgK396Bw1d8qXF4cl7fEHG0heC7enVfrBU3piQP4gX_YPTL7p9J5BFQMqQ4QIBXmAbHqUDUwOdFWJQIAdcRYBiEv_55XoEcKu109H9vo3eCHM8RlUHJv-w3FNAz4A_9HJ5oX9zTb-HTSekg1677LF31iKr0SOYHO90-soE=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>and<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIZbbYhOx0ijcJOj7Ty268cfMMpt-m36h0q2bduW4Bnijd0bqw2_Zz20abRONEqxJphyX7s9JMqsiAM09geMCinS9hkznW7H-JEVugSjI1s5JpqBIpcPC7KYlzam0FcIuOHESooXSWMxPOeCi2QE9l_A=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Em24bSTnyZXSUrp3q_yE1dySF7G57AXGWk5Sb5q-zd9oxEKeBruF1SEVlaFnSaIuaqB85yOrY2kIxkE7yCfw6Jl6cf8wjqgm301N4cH5W_W2BuAM5_sI_xcBTAP02wbJVoZrKmSG8H39QwW2zm4zLq8L6H4i1bfPtvEkkHS22QHLxPcpK9BAsxTZxcMTZwxk\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>support\/neuroendocrine<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIV4AMCrJeQeB-yfV87kkcWCkFvjanta3qxlA91vw9-FBWCxSUVUTo-nXYH4s-di0FT2Je6CbA_f7jqkKeIku5O_41Z7cyGIf8z3ykHwXZ5cJZ6Buq1OpuFMyeN0ylTTlFLu6_Slpvl3515QvbBXieYc=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V-Mf12InKUI6DnhM2fGT8ToYQqi__3JMe77Ai5FaX-rC1eAM1zeaEQyqT1raC6f5Jy4VlsDBmCst8GahS0vlokZks8pdtnjdXuvsxG0NBlHoVeM4icMxidjU-QM4Lvsx-KyjjqteX1nVytOHj4psdWlxAksrgaCgXGnmjP14hZA=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>tumours<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIWZbjPOES4bGCt9Hhn_CUYDLIf27mLGWndyUhjR_ncJgnYzNxYUHVtEl4rhAZAv9WQdtDjeXw9wu0kkb4U5JpYO9uJxk4E9Q3N4XjeACp4cCceZjD9-E4EhJOZHH5WyXM-fD673hzyeCwMgOatNjBoY=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pQb4S7jTEDMOwuhBb7EJDkkyMrkj09wLmzvb8oGfMz2zWZYbKCXclqp6oEKQ0Nge9ucfDo8iPn9QXy3NTQ0gNbNqhfoNm4bW9nsF1s77o8JxKShSKxWPem3PG9q2hTy1LY8krmvt8YeMIn3vojkc8NAI6vzkXulh6wXnyMPd88k=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>nets.<\/b><\/a><\/li>\n<li style=\"margin-bottom:3px\">Zekri\u00a0<em>et al.<\/em>\u00a0Neuroendocrine tumor of the kidney: Diagnostic challenge and successful therapy.\u00a0<em>Urology Annals<\/em>. 2019;11:4, DOI:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GNP0ev44d6XHeNzX0M24HiRxnd9hT1uPv2ANbgh7vPmQH1nWTOpEwiBK2G0h_C3uoRQ2tuICC2AtQI8WYriY5aXDWEbv7UnVEQE7S6sE_stiZYND5_p5pioT6RDL6uhs6M8RL4wTf6imoEn4EMQtpA==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>https:\/\/doi.org\/10.4103\/UA.UA_169_18<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jXKOpPJY_N7ck2XlnPCTd-swoAizcY-0rK3OoYfGsFq0cslHq3BAQMUVkZwPrFA2ivGXatft_ILqAYLrA3vUZpvLp3aPQgZRo81JQ-ZbTWE=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>.<\/b><\/a><\/li>\n<li style=\"margin-bottom:3px\">Dasari A.\u00a0<em>et al<\/em>. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.\u00a0<em>JAMA Oncol<\/em>. 2017 Oct 1;3(10):1335-1342, DOI:<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mPVv0tYSEKKuWo8DUhE_Y4569WIlX08fV3izkIJQZLVALTkSvpFixiFRjoSdW3Pvzeb73nvLaTHkOKeCKrMqlD4OYZ20LARJwrSYMSkIKtkRR0jPz8NgZuan-6zLQk3_36OKkuncRlk1nGvR7NBG2g==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>10.1001\/jamaoncol.2017.0589<\/b><\/a><\/li>\n<li style=\"margin-bottom:3px\">Hendifar, A.E et al. Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease. Journal of Thoracic Oncology. 2017;12(3): 425-436, DOI:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GNP0ev44d6XHeNzX0M24HiRxnd9hT1uPv2ANbgh7vPmX8N-zMLQzut2h0eIo-BRrjLZoPnq-Kp-bLAZUV-hIeghhEOTucPASD2kQzwuYLg1N8KhehIvPUs6RvPb8yN0hWNVp0nvVgKeKEMkrS_J7MI8aLEsACVutis9PY8Bv15c=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>https:\/\/doi.org\/10.1016\/j.jtho.2016.11.2222<\/b><\/a><\/li>\n<li style=\"margin-bottom:3px\">Hallet JC.\u00a0<em>et al<\/em>. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121:589\u201397, DOI: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zOCKjXw--Wg9f_EmuH4DyvnAVhDFd60iwEwrpAbuaJxB7vK9oa1F1bRO4JN-v_eWBzWd6opkBQp4ijNHq8Igk3qRILyMnKS9jf4kk6SMjT1I2CsxEbf5fRj3mJhRZr5E\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\">https:\/\/doi.org\/10.1002\/cncr.29099<\/a><\/li>\n<li style=\"margin-bottom:3px\">Mayo Clinic. Carcinoid syndrome. Last accessed: February 2022. Available from:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GNP0ev44d6XHeNzX0M24Ho30r54BGFiAFNBTMj3OtiLVbzaoaORDl3kNme_G5_f5hnDpkrliFR8kJGS5myTE-VkY7fdAjKcdi-BaMhDqy5cErtRk3SJydfS2iX2nLnd32nwZU52WphmE600kvJr3KS7lrKYaBS0bedvS1LliXkwJrdXW1l2QQj9XvESajfbYczwuxLbR1LANZ0YtKndWmg==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>https:\/\/www.mayoclinic.org\/diseases<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIYeOUXubeFCp_CtEIyF9Ek6yVFJfhceoMEt0ITaby0O7lAekCRISxQ-xx4NJpG2DlBg62P0Vg1TCWM_z7RFjQ3kr9iGcWxUeLV1ocQtsPKnWZseGvNV9Kumrcvt1ZJ_51fN4pORuRdO0o1u2MacN7oI=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ONE0ixUzCQX3TVtLqjupc7fgi1LKzqHM5K3FNtICw1ZsPquQM96KOqkEJDfDEO86nZjUZFQZGfYe7CjHTVak9r6GECOro_cYM5IRsb1C35WsnjeMyuVL7r3vvivvBA_OhpQzQqQp-KoTFUJidYf-pKPGmeWbV1hBXvJjGL5kaxOJoxcOpq6CpYfYTmUvFbEQ\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>conditions\/carcinoid<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIb_3zHGNTj2CqIqyw3FnbJgraWktR85sUmtcm9Z86ZiphRlrWXMoEPFjDUVSlqFBMYOtt616zKPiY_nKBawn7EakUA6muAQ02n_JJJ0c8UhzpbriOPb2aFwdPNiKy8tRkAjT13Pw7RhuZPeiCN_IIvM=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WikRtcNTYr9T3BC4IGt0NjyoR4SOHQXsdwTk3LMlGVgTUWtTfamWR-ULKN7UNFHOTJprs7wkbt-1CQVEPkiKiLVXWWIVglfIn2fRK9J6KSQVQMk35jZEY3IeKkqQ4czPLoaIX0pD01_jBB20Xbxux1QFA2DO4fEHj7O6p6oyHt8fUcwobcuiZIJr72qOL1FM\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>syndrome\/symptoms<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIcYBR4NJ6P514aGf23wsngvk8HjGdPfSL5nDoRiEIl-LG4sXa4eAx_egrR4T4U5ULrEyF1lWoAE9XujWmdSddXOM_H9ZizTTnYzFMODb9Mq9Qqu1LI3PWJoigekK79XUIwPcehAw2RNo0yiH9o9u1Uk=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L8sNURbr0pQ15t7SrctKanJAb-EvoOGpiDY_n7_Exs9lZgf4ZaprS6xeCiVtZ3mtC56B8xFL4Y74tUO1LIDvzzJn3NbjjVgXprkjNkD8kqqzmhAUDzuBSPMGHDdj5GTilLEL6XA6xaYwr5_-aPdB1B2wyUG4DA5qhlVd_pRyIU-AbavPhavdNwPygUTE7C8k\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>causes\/syc<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIWYkIixTrZcZt42ll1tbN4fTz9jby6szO_V_1yEFq1DXpHz7EzG08mm7YJsDMcylmvqWtAjKGm2hmxA4PTgxLVhbUctXFiLDokEz24Gl83nzG1hfzl9P7P0ZfcDCqQ4uPxOk_uWrUHTgpPPlU4IwEKc=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=29V2la9nNCXcRHi61QMsUcD_ItEbJC7WJQHTZwtAu5E7941s1pMTJUoj-3z0aK20xAWr13IaJSLXe7CGyA4nzJ9siLdADlwsxR0UAJOgc8E-SB3oV4mTD6ePEugENzB0r5YfQUx2udsGOi2BNqEXpxc9__J1EVJGKLlyym3yj3EXSxMurm1jGEtb2L4vmau1\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>20370666<\/b><\/a><\/li>\n<li style=\"margin-bottom:3px\">Mayo Clinic. Acromegaly. Last accessed: February 2022. Available from:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GNP0ev44d6XHeNzX0M24Ho30r54BGFiAFNBTMj3OtiLVbzaoaORDl3kNme_G5_f5uOjwNW7U5gF_P8W47l6OBLqks3SsBsM6APfMvtwiy5jJEO3ksDG52XQOcHqfJDzsTLF5Gz-CljlwaKvNk6R0iEjMDalMkchy7oKG5HZfHBPzfvVosgNd99kwLchksdV52wXXEvnG0K3VmmLyG1T-6A==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>https:\/\/www.mayoclinic.org\/diseases<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIYIUZYHmliULIxV03p725_C1dJ2CsrEfDogpPZgnxlqe5UcT8E3hqKpWc9hwarrXVOZThBW-YMiCGZITNUNBEuj-J0IsX2Ybvza-5Xd4T8cgfZIiG7aV3D4r92kAI5orTEnXL6MJ381a9q2lpvwcSHU=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ONE0ixUzCQX3TVtLqjupc7SBnb4d5dObSFnwKP3NO-Kg39_nFrIE2rdj88z7POhJ95wt_OpgXxKrMzQ6UFqkzMgeDwbBHwbT-dCC59usDNzM2l_m6e5ut6g5z6qmVK_EOIDJKxXkr6I2Wju5Or6OY2jGrF2Pru1pGtfzk6nrM7v1WMmlT1r3JjaWpaWZyqzY6yPQtdi53CJskD3yBMHayA==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>conditions\/acromegaly\/symptoms<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIR-MM2Uen9Hwdlt7b4BNvjHXFYSx20gLjknaX8JZLynvJTOi2sXjnU0YuZS96ERVMzB-d94OsoXxviewjLhaqbneU-fIcxbbR9vhXcAPLJmadxnv7IZfJgsxDuarW_SA2eIAHbteYPsPpJN9nUkqJRw=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L8sNURbr0pQ15t7SrctKaqsCqwH5sLfoSbju0zZyt91WnFy96La9zwk45lb85DGXZgIAkbwStVGdkbSVsi1PEXLdZbRTsZNWSO6hkDCdmA34DWajHQ7YaKxENdDxUsa1ZyitmA6uSq46_mXaToKGmLuYUD_HgGTO7O6mmF1ZPzY=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>causes\/syc<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2HXxwA2XW89wonw9AMzxIbzx9NRs179ZnRiu9nsUuos35E30BIK4Bv8vzXtuulZtD4tQN0NZjyVp4tTFcbGJ-r68ElPeYfYOu5I0LLNLJxEP-mX7Nq7J_IGq4Jo3by0KpN4iOJdCWP4RZrO2PhEHAm1fFmD5s8fVtMPpHDR-bxU=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>\u2013<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=29V2la9nNCXcRHi61QMsUU652p06-0UW6ISaOPjxmrFzmUZuM011z-DznY22G1fFGwbob2FW6HZ4IMIsfXrcW99Luy0ZQQyZWIT5_ktH78qIQrf6YUA2SxmU8WqdAlpFLU5jrOHkHWtj1W782sWuMJ4Ke17OrYQ_P5uhP7uQMo4=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>20351222<\/b><\/a><\/li>\n<li style=\"margin-bottom:3px\">Acromegaly. Last accessed: February 2022. Available from:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GNP0ev44d6XHeNzX0M24HqY1hFmyqUIX9TohlzK6TXWWxuR_hLiYGYZ08pWjWk0r3LoF2qDSnv6A_Ju88RPRQznTiEbZpJezFmeRbZh5bULSlMnI_Pwtj8hpT-uP5SfTGTxrVVMVjo5fxsepPfvbWg==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>https:\/\/rarediseases.org\/rare<\/b><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Np4Kl4qsWEyqb126V8I0Yoh4zvaz-FCKfxPG2fx_wngb4N50z1Dpng_Ut8j-23ZsWEslSkpWQP9n2h43DRjDHbM_JSe0WjKeYY67cem1Pr4xULZ2mv6rGR5l84G1xGoSh9l99Ls-3APXBSQyV07Lkg==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><b>diseases\/acromegaly\/<\/b><\/a><\/li>\n<\/ol>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Pi\u00e8ce jointe<\/strong>\n<\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=U85Ri0caBhYqnlqk_ACFFifUSkpKxAYgRyEWwfTPnUHVvI03-Qbs3it20aSEPi7UeWxVcy1_DhBHw6z9IEnMO7MWIZINvUnL7fx0qHZBvMWUjq62WEv8iLq88P6dSfACOH5UUkCuqFS-k1_tt5BqU_e5scywk0NbRCrRvoye2RMoH5-wvTwTmALKunKlmYNnZN8NRPUHrU_P1K1zoGb4T6WepYxSLH8_YxlRyaVqwvE=\" title=\"Ipsen-Somatuline-Autogel-Depot-Electronic-Autoinjector-16-Mars-2022\" rel=\"nofollow noopener\">Ipsen-Somatuline-Autogel-Depot-Electronic-Autoinjector-16-Mars-2022<\/a>\n      <\/li>\n<\/ul>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[3556],"tags":[],"class_list":["post-34159","press_release","type-press_release","status-publish","hentry","category-corporate-pressrelease-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients - Global<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients - Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/\",\"name\":\"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients - Global\",\"isPartOf\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2023-08-15T21:54:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients - Global","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients - Global","og_url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/","og_site_name":"Global","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/","name":"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients - Global","isPartOf":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#primaryimage"},"image":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2023-08-15T21:54:05+00:00","breadcrumb":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/YzczZjE1N2YtZjVkMC00ZDBhLThkYjItMGM2ZDg3NzI3OTMwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/press-releases\/ipsen-annonce-son-investissement-dans-un-dispositif-electronique-innovant-dauto-injection-de-somatuline-autogel-somatuline-depot-lanreotide-concu-pour-ameliorer-l\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/"},{"@type":"ListItem","position":2,"name":"Ipsen annonce son investissement dans un dispositif \u00e9lectronique innovant d\u2019auto-injection de Somatuline\u00ae Autogel\u00ae \/ Somatuline\u00ae Depot (lanr\u00e9otide), con\u00e7u pour am\u00e9liorer l\u2019exp\u00e9rience des patients"}]},{"@type":"WebSite","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization","name":"IPSEN","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/press_release\/34159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/press_release\/34159\/revisions"}],"wp:attachment":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/media?parent=34159"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/categories?post=34159"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/tags?post=34159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}